Vaginosis bacteriana y vaginitis inflamatoria descamativa

REFERENCIAS

1. Marrazzo J, Sobel J, Hillier S. Vaginal infections. In: Morse SA, Ballard RC, Holmes KK, Moreland AA, eds. Atlas of sexually transmitted diseases and AIDS. 4th ed. Philadelphia: Saunders, 2010: 76-93.

2. Muzny CA, Schwebke JR. Vaginal infections. In: Goldman M, Troisi R, Rexrode K, eds. Women and Health. 2^nd ed. London: Academic Press, 2013: 473-83.

3. Carr PL, Rothberg MB, Friedman RH, Felsenstein D, Pliskin JS. “Shotgun” versus sequential testing: cost-effectiveness of diagnostic strategies for vaginitis. J Gen Intern Med 2005; 20: 793-9.

4. Hillier SL. The complexity of microbial diversity in bacterial vaginosis. N Engl J Med 2005; 353: 1886-7.

5. Cohen CR, Lingappa JR, Baeten JM, et al. Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples. PLoS Med 2012; 9(6): e1001251.

6. Hillier SL, Nugent RP, Eschenbach DA, et al. Association between bacterial vaginosis and preterm delivery of a low-birthweight infant. N Engl J Med 1995; 333: 1737-42.

7. Eschenbach DA. Bacterial vaginosis and anaerobes in obstetric-gynecologic infection. Clin Infect Dis 1993; 16: Suppl 4: S282-S287.

8. Smith SB, Ravel J. The vaginal microbiota, host defence and reproductive physiology. J Physiol 2017; 595: 451-63.

9. Muzny CA, Blanchard E, Taylor CM, et al. Identification of key bacteria involved in the induction of incident bacterial vaginosis: a prospective study. J Infect Dis 2018; 218: 966-78.

10. Mitchell C, Fredricks D, Agnew K, Hitti J. Hydrogen peroxide-producing lactobacilli are associated with lower levels of vaginal interleukin-1beta, independent of bacterial vaginosis. Sex Transm Dis 2015; 42: 358-63.

11. Godha K, Tucker KM, Biehl C, Archer DF, Mirkin S. Human vaginal pH and microbiota: an update. Gynecol Endocrinol 2018; 34: 451-5.

12. Gajer P, Brotman RM, Bai G, et al. Temporal dynamics of the human vaginal microbiota. Sci Transl Med 2012; 4: 132ra52.

13. Verstraelen H, Verhelst R, Claeys G, De Backer E, Temmerman M, Vaneechoutte M. Longitudinal analysis of the vaginal microflora in pregnancy suggests that L. crispatus promotes the stability of the normal vaginal microflora and that L. gasseri and/or L. iners are more conducive to the occurrence of abnormal vaginal microflora. BMC Microbiol 2009; 9: 116.

14. Gardner HL, Dukes CD. Haemophilus vaginalis vaginitis: a newly defined specific infection previously classified nonspecific vaginitis. Am J Obstet Gynecol 1955; 69: 962-76.

15. Roberts MC, Hillier SL, Schoenknecht FD, Holmes KK. Comparison of gram stain, DNA probe, and culture for the identification of species of Mobiluncus in female genital specimens. J Infect Dis 1985; 152: 74-7.

16. Hillier SL, Critchlow CW, Stevens CE, et al. Microbiological, epidemiological and clinical correlates of vaginal colonization by Mobiluncus species. Genitourin Med 1991; 67: 26-31.

17. Schwebke JR, Lawing LF. Prevalence of Mobiluncus spp among women with and without bacterial vaginosis as detected by polymerase chain reaction. Sex Transm Dis 2001; 28: 195-9.

18. Burton JP, Devillard E, Cadieux PA, Hammond JA, Reid G. Detection of Atopobium vaginae in postmenopausal women by cultivation-independent methods warrants further investigation. J Clin Microbiol 2004; 42: 1829-31.

19. Ferris MJ, Masztal A, Aldridge KE, Fortenberry JD, Fidel PL Jr, Martin DH. Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis. BMC Infect Dis 2004; 4: 5.

20. Marconi C, Cruciani F, Vitali B, Donders GG. Correlation of atopobium vaginae amount with bacterial vaginosis markers. J Low Genit Tract Dis 2012; 16: 127-32.

21. Fredricks DN, Fiedler TL, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med 2005; 353: 1899-911.

22. Kenyon C, Colebunders R, Crucitti T. The global epidemiology of bacterial vaginosis: a systematic review. Am J Obstet Gynecol 2013; 209: 505-23.

23. Onderdonk AB, Delaney ML, Fichorova RN. The human microbiome during bacterial vaginosis. Clin Microbiol Rev 2016; 29: 223-38.

24. Marrazzo JM, Martin DH, Watts DH, et al. Bacterial vaginosis: identifying research gaps proceedings of a workshop sponsored by DHHS/NIH/NIAID. Sex Transm Dis 2010; 37: 732-44.

25. Srinivasan S, Morgan MT, Fiedler TL, et al. Metabolic signatures of bacterial vaginosis. MBio 2015; 6(2): e00204-e00215.

26. Mitchell C, Marrazzo J. Bacterial vaginosis and the cervicovaginal immune response. Am J Reprod Immunol 2014; 71: 555-63.

27. Chen KC, Amsel R, Eschenbach DA, Holmes KK. Biochemical diagnosis of vaginitis: determination of diamines in vaginal fluid. J Infect Dis 1982; 145: 337-45.

28. Mehta SD. Systematic review of randomized trials of treatment of male sexual partners for improved bacteria vaginosis outcomes in women. Sex Transm Dis 2012; 39: 822-30.

29. Amaya-Guio J, Viveros-Carreno DA, Sierra-Barrios EM, Martinez-Velasquez MY, Grillo-Ardila CF. Antibiotic treatment for the sexual partners of women with bacterial vaginosis. Cochrane Database Syst Rev 2016; 10: CD011701.

30. Marrazzo JM, Thomas KK, Agnew K, Ringwood K. Prevalence and risks for bacterial vaginosis in women who have sex with women. Sex Transm Dis 2010; 37: 335-9.

31. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991; 29: 297-301.

32. Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. Nonspecific vaginitis.: diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983; 74: 14-22.

33. Gaydos CA, Beqaj S, Schwebke JR, et al. Clinical validation of a test for the diagnosis of vaginitis. Obstet Gynecol 2017; 130: 181-9.

34. Hardy L, Jespers V, Dahchour N, et al. Unravelling the bacterial vaginosis-associated biofilm: a multiplex Gardnerella vaginalis and Atopobium vaginae fluorescence in situ hybridization assay using peptide nucleic acid probes. PLoS One 2015; 10(8): e0136658.